Clinical Development Pipeline
| Program Indications |
|
Worldwide rights |
|||||
| KINETIC COVID-19 hospitalized patients (severe) |
|
 |
|||||
| KINFAST COVID-19 ambulatory patients (mild-to-moderate) |
|
|
|||||
| KIN001-AMD Wet-AMD patients (maintenance of vision) |
|
|
|||||
| KIN001-IPF Idiopathic Pulmonary Fibrosis (rare lung disease) |
|
|